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Dental implant treatment has been widely used for oral reconstruction in recent years 
thanks to the advent of osseointegration and advances in biomaterials. A prerequisite to 
predict long-term success for osseointegrated implants is a sufficient bone volume at 
recipient sites. Vertical alveolar bone loss in partially or totally edentulous patients 
presents a major challenge in the field of implant dentistry. Although autogenous bone 
is regarded as the gold standard in regenerative dentistry, its various limitations 
stimulate the search for alternatives. Engineered bone tissue using bone morphogenetic 
protein 2 (BMP-2) has been seen as a potential alternative for the conventional use of 
bone grafts. However, most current commercial products deliver BMP-2 in a burst 
release mode, which leads to a number of side effects.  
In Chapter 2, we made a systematic literature review and meta-analysis to 
investigate the efficacy of rhBMP-2 in vertical bone augmentation using bone 
substitutes in preclinical experiments (animal studies). No statistically significant 
difference was found in the percentage of newly formed bone and residual materials 
between the groups with and without rhBMP-2. The tissue regeneration was 
significantly improved by the additional use of rhBMP-2. With the application of space-
providing barriers, the augmented bone height was also significantly enhanced by using 
rhBMP-2. These results are limited by the small number of included studies and a high 
degree of heterogeneity. Consequently, there is not enough evidence to support the 
current application of rhBMP-2 for vertical bone augmentation in routine clinical work. 
The key point for improving the efficacy of BMP-2 is to find an appropriate carrier 
which can give and maintain a sustained delivery of low doses of BMP-2 (in the 
microgram range). A biomimetic calcium phosphate (CaP) coating was developed in our 
previous study as a carrier of BMP-2. In Chapter 3, we functionalized the deproteinized 
bovine bone (DBB) block with this biomimetic CaP coating incorporating BMP-2, and 
evaluated the release kinetics of the incorporated BMP-2 in vitro. The results showed 
that BMP-2 was successfully incorporated onto and into the DBB blocks and a 
sustained delivery of BMP-2 from the DBB blocks was achieved with the mediation of 
osteoclasts. 
After proving the in vitro slow-release characteristics of incorporated BMP-2, in 
Chapter 4, we investigated its potential in replacing autogenous bone in vertical bone 
augmentation in vivo. DBB blocks with incorporated BMP-2 (inc.BMP-2), with 
superficially adsorbed BMP-2 (ad.BMP-2), or without any functionalization (negative 
control) are used in the one-stage onlay surgery and examined for their new bone 
formation. The results are compared to those from the autologous bone blocks (positive 
control). The inc.BMP-2 group and the positive control showed a similar efficacy for 
vertical bone augmentation. They both exhibited a significantly thicker and wider 
augmented bone area, better bone-to-implant contact, and more mineralized tissue than 
the negative control. Furthermore, the inc.BMP-2 group induced significantly more 
newly formed bone in the upper half of the volume of interest (VOI-U) than the negative 
control. Compared with the ad.BMP-2 group, the inc.BMP-2 group showed significantly 
more mineralized tissue, better bone-to-implant contact and better bone-to-graft contact. 
This indicates that the efficacy of BMP-2 was significantly enhanced by the biomimetic 
CaP coating as a carrier for the slow and sustained delivery of BMP-2. Combined with 
the fact that DBB block has a slow rate of degradation, we propose that DBB block with 
coating-delivered BMP-2 can act as an appropriate bone substitute for the vertical bone 
augmentation. 
Another prerequisite for the successful ossteointegration is the favorable surface 
properties of the implant materials. Commercially pure titanium has been regarded as 
the gold standard for osseointegrated dental implants but its greyish color might shine 
through the thin peri-implant mucosa and affect the esthetical outcome. A zirconia 
implant has been proposed as an alternative for a titanium implant because of its 
toothlike color. The surface property of zirconia implants is important in peri-implant 
bone apposition in the same way as for titanium implants. In Chapter 5, we 
functionalized the zirconia implants with our biomimetic CaP coating with or without the 
incorporation of BMP-2 and investigated their histological behavior in vivo. We found 
that the application of the biomimetic CaP coating incorporating BMP-2 enhanced the 
peri-implant bone density significantly for zirconia implants. This indicates that our BMP-
2 incorporated biomimetic CaP coating has a histologically positive influence on the 
osseointegration for zirconia implants.  
While BMP-2 functionalized CaP coating enhances the osseointegration of the 
implants, the long-term success of dental implants is also affected by their integration 
into the soft tissue. In order to enhance the attachment of the implant neck with its 
adjacent soft tissues, we developed a modification of the implant neck surface in 
Chapter 6. We used anodic oxidation (AO) to roughen the surfaces of implant necks 
and applied a layer of polydopamine (PD) on the roughened surfaces. In vitro 
investigations showed that the surfaces of anodized implant necks were overlaid with 
densely distributed pores of 2–7 μm in size with a roughness of 
Ra = 1.3745 ± 0.2016 μm. PD was successfully deposited on the PD-modified surfaces. 
L929 fibroblasts developed pseudopods more quickly on the PD-modified surfaces than 
that on the surfaces of the control. The in vivo experiment showed a longer connective 
tissue seal for implants treated with AO (the AO group and AO + PD group), compared 
with those without (the PD group and control group). A more coronally located peri-
implant soft-tissue attachment was also observed in the AO + PD group, compared with 
that in the control group. Therefore, the implant neck modified by anodic oxidation and 
polydopamin deposition can enhance the attachment of peri-implant connective tissue, 
inhibit epithelial downgrowth and facilitate the formation of the peri-implant soft-tissue 
seal, thus indicating a positive effect on maintaining its stability. 
We conclude that when applied in a coating-delivered mode, bone morphogenetic 
protein 2 can enhance the vertical bone regeneration for one-stage onlay surgery as 
well as the peri-implant osteogenesis for zirconia implants. A new design of anodized 
implant neck with pholydopamin deposition can enhance the attachment of peri-implant 
connective tissue and facilitate the formation of the peri-implant soft-tissue seal.  
 
